Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
HLRCC – A patient’s perspective
Antony Horton
In September 2011, I paid a routine visit to a dermatologist at the Beth Israel Medical Centre, New York City, for a general consultation on a skin condition that had affected me for several years. Having had numerous unsightly and sometimes painful ‘skin-bumps’ removed over many years, this visit did not seem particularly special. I was previously told that these ‘skin-bumps’ were actually called ‘leiomyomas’ and took the form of a benign tumour of smooth muscle cells, originating from within the erector-pili of hair follicles. On this particular occasion, my dermatologist took a more detailed family history and flagged up something I was not previously aware of, a condition called ‘Reed’s syndrome’. This condition is also referred to by the more descriptive terms: multiple cutaneous and uterine leiomyomas and hereditary leiomyomatosis and renal cell cancer.
Dermatology in practice
2015;
21
(3): 63–63
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
Gilead and LEO announce $1.7bn inflammation deal
Regeneron’s Libtayo shows promise in phase 3 high-risk skin cancer trial
Bristol Myers Squibb shares promising phase 3 results for Sotyktu in psoriatic arthritis
FDA grants approval to Organon’s Vtama cream in atopic dermatitis
EMA committee recommends Galderma’s nemolizumab for prurigo nodularis and atopic dermatitis
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy